Document ID: chunk:federal_register_of_legislation:F2023C00019:clause:1_35
Version: federal_register_of_legislation:F2023C00019
Segment Type: clause
Provision Reference: sch 1 cl 35
Character Range: 52186–53808

35  General restrictions
  A price information list must not:
 (a) present or describe a medicine in a way that directs consumers to a particular medicine over and above any other medicine, whether or not that particular medicine is mentioned in the price information list; or
 (b) be accompanied by any promotional statement, pictorial representation or design; or
 (c) include:
 (i) an adjective or phrase that qualifies the name, formulation or pack size of the medicine; or
 (ii) a term indicating the predicted or recommended length of supply; or
 (iii) any embellishment; or
 (d) promote the purchase of quantities or multiple pack sizes that are not accepted in relation to the inclusion of the goods in the Register, except as provided under section 34; or
 (e) use a comparative adjective or term to qualify the purchase price of the medicine; or
 (f) give any prominence to the text of the name, description or purchase price of a particular medicine compared to any other medicine in the price information list; or
 (g) offer rewards or bonus points, or be associated with any other advertising that promotes rewards or bonus points; or
 (h) limit or qualify the availability of the price, other than by including a statement of validity or expiration of the purchase price; or
 (i) be accompanied by, or located in proximity to, information (including implications or references to other sources of information) regarding indications, diseases, conditions, ailments or defects, so that a reasonable person might infer that the medicine would cure or alleviate those diseases, conditions, ailments or defects.